DUBLIN--(BUSINESS WIRE)--The "Paediatric Consumer Health in the US" report has been added to ResearchAndMarkets.com's offering.
Although COVID-19 cases have risen among children in the summer months, studies have shown that children are less likely than adults to catch COVID-19. In the US, children (0-17 years) make up only 7.3% of all COVID-19 cases, although demographically they represent 22% of the US population. Studies have also shown that children experience milder symptoms than adults when they do contract COVID-19.
The Paediatric Consumer Health in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Paediatric Consumer Health market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market's major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Key Topics Covered:
1. KEY DATA FINDINGS
2. 2020 IMPACT
- Sale of paediatric products expected to decline faster than their adult counterparts in second half of 2020
- School closures and store restrictions limit children's exposure to illnesses
- Benefiting from its natural positioning, Zarbee's sees growth across categories
3. RECOVERY AND OPPORTUNITIES
- Return to in-person schooling expected to increase demand for paediatric cold medication
- Disruptions in paediatric vaccinations leave children exposed to various illnesses
4. CATEGORY DATA
5. EXECUTIVE SUMMARY
- COVID-19 impact on consumer health
- COVID-19 country impact
- Company response
- Retailing shift
- What next for consumer health?
6. MARKET INDICATORS
7. MARKET DATA
8. APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2019-2020
9. GLOBAL MACROECONOMIC ENVIRONMENT
10. GLOBAL INDUSTRY ENVIRONMENT
11. DISCLAIMER
12. DEFINITIONS
13. SOURCES
For more information about this report visit https://www.researchandmarkets.com/r/ph30no
